Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1422 of 5804
-
Hope for schwannomatosis pain: new drug trial launches
Symptom relief Recruiting nowThis is a placebo-controlled, multi-arm phase II platform screening trial designed to test the safety, pain responses, and pharmacodynamic activity of multiple experimental therapies simultaneously in participants with moderate-to-severe pain due to schwannomatosis (SWN). This M…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New study tracks SUBLOCADE users for 4 years to see if recovery lasts
Disease control CompletedThis study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioi…
Sponsor: Indivior Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for kidney transplant patients: drug may prevent rejection with fewer side effects
Disease control CompletedThis study will evaluate the safety and efficacy of AT-1501 compared with tacrolimus in patients undergoing kidney transplantation.
Phase: PHASE2 • Sponsor: Eledon Pharmaceuticals • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study, the first clinical trial of AVZO-021, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and anti-tumor effects of AVZO-021 in patients with advanced solid tumors. AVZO-021 is an oral medication that inhibits cyclin…
Phase: PHASE1, PHASE2 • Sponsor: Avenzo Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for tumors that beat immunotherapy? early trial launches
Disease control Recruiting nowThis is a Phase 1a/1b, dose-escalation/expansion, consecutive-cohort, open-label study to evaluate the safety, tolerability, PK, PD, and preliminary evidence of antitumor activity of PLN-101095 in combination with pembrolizumab (the study treatment regimen) in adult participants …
Phase: PHASE1 • Sponsor: Pliant Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Can freezing nerves before knee replacement cut opioid use?
Symptom relief OngoingKnee osteoarthritis is a major issue worldwide with limited treatment options. Many patients receive knee joint replacement surgery which is considered effective and safe. Nonetheless the period post-surgery is characterized by moderate to severe pain inhibiting early ambulation,…
Phase: NA • Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Music as medicine: new trial tests Stepped-Care therapy for veterans in pain
Symptom relief Recruiting nowTh Stepped-Care Intervention of Music and Imagery to Assess Relief (SCIMITAR) Trial. SCIMITAR builds on our pilot study, the Feasibility and Acceptability of Music Imagery and Listening Interventions for Analgesia (FAMILIA), which demonstrated that telehealth delivery of music li…
Phase: NA • Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New combo surgery aims to save knees from osteoarthritis
Disease control Recruiting nowThis is a prospective randomized double-blind controlled clinical trial with parallel arms and 1:1 allocation. The main objective of the BIOMAT project is to demonstrate, through an RCT, whether the combined approach by knee osteotomy and MAT can provide clinical improvement ove…
Phase: NA • Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Rural ERs get a lifeline: poison center telehealth aims to start opioid treatment on the spot
Disease control Recruiting nowThe overarching goal of this project is to increase the availability of OUD treatment in rural counties in the state of Georgia by using Emergency Department (ED)-based telehealth strategies to initiate MOUD and connect patients to treatment. The investigators will implement a n…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Inhaled sirolimus trial aims to ease breathing in lung scar patients
Disease control Recruiting nowA Phase 2, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LAM-001 in Adults with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD).
Phase: PHASE2 • Sponsor: OrphAI Therapeutics • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a pill replace IVF shots? new study tests oral drug
Disease control CompletedThis study is a multi-center, randomized, double-blind, positive drug-controlled, non-inferiority Phase III clinical trial. The study will enroll approximately 316 infertile female subjects undergoing controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF) or i…
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:58 UTC
-
Double radiation attack on prostate cancer shows promise
Disease control Recruiting nowThe objective of this phase I/II trial is to prospectively evaluate the toxicity and therapeutic efficacy of Stereostatic Body Radiation Therapy (SBRT) to prostate and pelvic lymph nodes in combination with high-dose-rate (HDR) brachytherapy to the prostate in patients with local…
Phase: NA • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug duo aims to halt hard-to-treat endometrial cancer
Disease control OngoingTo learn if the combination of DKN-01 and pembrolizumab can help to control advanced or recurrent endometrial cancer.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Old gout drug could help hearts of people with type 1 diabetes
Disease control OngoingThe aim of this clinical trial is to evaluate if colchicine in addition to standard of care improves markers of inflammation and cardiovascular disease in persons with type 1 diabetes. Participants will be assigned to either 0,5 mg colchicine daily or placebo in a 1:1 ratio for 2…
Phase: PHASE2 • Sponsor: Asger Lund, MD • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Myeloma breakthrough? study tests if patients can ditch lifelong drugs
Knowledge-focused Recruiting nowAn interventional, non-randomised study to assess the risk of progression after discontinuation of maintenance therapy in sustained MRD negative complete remission by flow cytometry MM patients without high-risk features who have completed at least two years of maintenance therap…
Phase: NA • Sponsor: University College Cork • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Could a simple pill let women start labor at home?
Symptom relief Recruiting nowThe number of women having an induction of labour is increasing and is currently used in 33% of pregnancies for a range of medical reasons. The majority of women are admitted to hospital to have their labour induced, using methods which are protracted and associated with a poor b…
Phase: PHASE2 • Sponsor: Chelsea and Westminster NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 26, 2026 16:40 UTC
-
New hope for Huntington's: Long-Term drug trial underway
Disease control OngoingThe primary goal of this study is to evaluate the long-term safety and pharmacodynamic effects of votoplam in participants with HD.
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a phone call ease warzone headaches? new trial tests virtual therapy for veterans
Symptom relief Recruiting nowPosttraumatic headache (PTH) is a common and highly disabling consequence of traumatic brain injury (TBI) in U.S. military service members and veterans. Cognitive Behavioral Therapy for PTH has been shown to significantly improve disability outcomes in veterans with persistent PT…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New study aims to boost heart health and cut stress in black men
Disease control Recruiting nowLower attainment of cardiovascular health (CVH), indicated by the American Heart Association's Life's Simple 7 (LS7; physical activity, diet, cholesterol, blood pressure, body mass index, smoking, glycemia) and Life's Essential 8 (LE8; LS7+sleep) metrics, is a major contributor t…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Brain training for the spine: new study aims to reduce spasticity and boost walking
Symptom relief Recruiting nowThe purpose of this study is to validate the capacity of a reflex training system to change the size of the targeted reflex. For this, the researchers are recruiting 25 individuals with chronic incomplete SCI who have spasticity in the leg to participate in the reflex training pr…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 26, 2026 15:09 UTC